Parkinson’s disease and sleep: understanding the problems

Why can Parkinson’s affect sleep?

Parkinson’s disease does not affect movement alone. The US National Institute of Neurological Disorders and Stroke lists difficulty staying asleep, night-time movement and vivid or emotional dreams among possible features. Brain networks involved in sleep and wakefulness may be affected, but this is only one part of the explanation.

Sleep can also be interrupted by stiffness, tremor, difficulty turning, painful dystonia, nocturia, anxiety or depression. Conditions that occur with or without Parkinson’s—such as obstructive sleep apnoea and restless legs syndrome—may add another layer. Dopaminergic medicines can also influence alertness or night-time symptoms.

Which sleep problems are important to recognise?

A 2024 review in The Lancet Neurology stresses that several sleep disorders may coexist in the same person and change over the course of Parkinson’s disease.

Can RBD be an early sign of Parkinson’s?

During normal REM sleep, activity in the limb muscles is markedly reduced. In RBD, this REM atonia is insufficient and a person may act out dreams. RBD is associated with synucleinopathies, including Parkinson’s disease, and can sometimes precede motor symptoms by years.

That association does not allow self-diagnosis. Talking in sleep, a brief movement, a nightmare or an isolated episode proves neither RBD nor a neurodegenerative condition. Clinical history and, when appropriate, video polysomnography help distinguish RBD from other parasomnias, sleep apnoea and night-time movements.

When behaviour is repeated or forceful, make the sleep environment safer while arranging assessment: remove dangerous objects, pad sharp corners, reduce fall risk and consider temporary separate sleeping if needed. The American Academy of Sleep Medicine clinical guideline highlights bedroom safety because injuries can affect both the sleeper and the bed partner.

Can medicines explain sleepiness or insomnia?

They can contribute, but they are not always the only cause. Dopamine agonists are particularly associated with daytime sleepiness and, in some people, sudden-onset sleep. Conversely, the timing and overnight effect of treatment may influence motor symptoms, dreams and wakefulness.

Do not stop, delay or reduce a medicine without advice. NICE recommends taking a detailed sleep history, excluding reversible causes and reviewing medicines before considering a treatment specifically for excessive daytime sleepiness. The right decision depends on the medicine, dose, timing, “off” symptoms, alertness and other health conditions.

How are sleep problems assessed?

1. Define the main pattern. Bedtime, sleep latency, awakenings, movements, dream enactment, breathing, wake time, naps and daytime alertness.
2. Include a partner’s observations. Breathing pauses, movements and sleep episodes may be clearer to someone else.
3. Review symptoms and medicines. Pain, stiffness, dystonia, nocturia, mood, caffeine, alcohol and medicine timing.
4. Use appropriate tools. Questionnaires and a diary can structure the consultation but do not diagnose a disorder.
5. Select testing when needed. Polysomnography may investigate RBD, apnoea or periodic limb movements; objective alertness testing is reserved for selected cases.

The NINDS Parkinson’s Common Data Elements guidance distinguishes actigraphy, polysomnography and sleep-latency testing according to the clinical question.

You can use the Sleeple 7-day sleep diary before an appointment. Add medicine times and unusual events, but do not interpret the summary as a diagnosis.

What measures may help?

• Treat the identified cause. Sleep apnoea, RBD, restless legs, night-time pain and depression require different approaches.
• Strengthen sleep-wake cues. A regular schedule, daytime light, suitable physical activity and a calm evening routine support sleep as a whole.
• Use the bed mainly for sleep. Long periods awake in bed can perpetuate insomnia, but this strategy must be adapted to mobility limitations and fall risk.
• Plan night-time safety. Keep the path to the bathroom clear, make lighting accessible, prevent falls and add stronger safeguards if dreams are acted out.
• Reassess rather than stacking products. Hypnotics, melatonin, clonazepam and wake-promoting medicines have specific indications and risks. An article is not a reason to start them.

Care should be cause-based and individualised. A 2025 German Society of Neurology guideline describes a stepwise approach that identifies the sleep problem before selecting treatment. Read the guideline.

When should advice be sought promptly?

• Sudden sleep, a near miss or sleepiness that makes driving unsafe.
• Falling from bed, hitting, injury or danger to a bed partner during dreams.
• Breathing pauses, choking during sleep or severe daytime sleepiness.
• New confusion, concerning hallucinations or an abrupt behaviour change.
• Rapid sleep deterioration after a medicine is started or changed.

For severe injury, persistent breathing difficulty or an immediate emergency, contact emergency services. For repeated but non-emergency problems, speak with the neurologist, primary-care clinician or a sleep clinic.

Frequently asked questions

Key points

• Sleep problems in Parkinson’s are common and often have more than one cause.
• Insomnia, sleepiness, RBD, restless legs, apnoea and motor symptoms need different responses.
• RBD is associated with Parkinson’s, but cannot be diagnosed from one dream or isolated movement.
• Sudden sleep means avoiding driving and contacting the prescriber.
• Never change Parkinson’s or sleep medicine without clinical advice.